CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

The Lancet
Original article

[Perspectives] Alison Holmes: sustaining global attention on AMR

PartnershipPositive
AI Analysis

Summary

Alison Holmes, Director of the Fleming Initiative at Imperial College London, discusses plans to leverage the 2028 centenary of penicillin's discovery to maintain global attention on antimicrobial resistance as a major public health challenge. She emphasizes the need for sustained policy focus and research funding to address AMR's disproportionate impact on vulnerable populations.

Importance:2/10
Sentiment:
0.30
antimicrobial resistanceglobal healthAMRresearch fundingFleming Initiativeinfectious diseases
Related Companies

Read the original article

Published by The Lancet on July 14, 2026 8:16 AM

Read Original